The DOI matches its Crossref record; 131 of the 137 references it cites were found in a registry or an index, and 1 are not checked yet.
Adeno‐associated virus vectors and hematology
Open accessAbstract
Gene therapists have a special fondness for hematology. Initially, this was due to the many inherited diseases that could potentially be cured by ex vivo genetic modification of hematopoietic stem cells. Once the early murine leukemia virus (MLV) vectors were found to transduce only a small percentage of primate stem cells, the search began for other types of vectors that might work more efficiently, and adeno-associated virus (AAV) vectors were among the first alternatives to be investigated. Although a substantial amount of work with AAV vectors has occurred over the last several years, the bulk of evidence suggests that they transduce hematopoietic stem cells poorly, and that they will not replace retroviral vectors in stem cell gene transfer applications. Instead, it is applications involving the production of secreted proteins that now appear especially promising for AAV vectors, where they are delivered by direct injection rather than ex vivo cell manipulation. Recent animal studies have shown that AAV vectors encoding factor IX can lead to long-term, therapeutic clotting factor levels after in vivo administration, setting the stage for what may well be a cure for hemophilia B in the near future. Animal experiments have also shown that AAV vectors expressing erythropoietin can produce dramatic increases in hematocrit levels. Here we will review the role of AAV vectors in the field of hematology, including the basic biology of AAV, vector transduction properties, their use in hematopoietic cells, and their potential for delivering secreted proteins such as clotting factors and cytokines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Despite many advances, gene addition approaches with adeno-associated virus (AAV) are limited by transient and unregulated expression,2”
From Adeno‐associated virus gene repair corrects a mouse model of hereditary tyrosinemia in vivo†‡ (2010) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Summerford, C., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1438-1445.1998 · Cited by 1,409
Xiao, X., Li, J., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2224-2232.1998 · Cited by 1,381
Kaplitt, M. G., Leone, P., Samulski, R. J., Xiao, X., Pfaff, D. W., O’Malley, K. L., & During, M. J. (1994) · Nature Genetics · doi:10.1038/ng1094-148 · Cited by 1,031
Adenovirus-Associated Defective Virus Particles
Atchison, R. W., Casto, B. C., & Hammon, W. M. (1965) · Science · doi:10.1126/science.149.3685.754 · Cited by 1,004
Xiao, X., Li, J., & Samulski, R. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.8098-8108.1996 · Cited by 913
Site-specific integration by adeno-associated virus.
Kotin, R. M., Siniscalco, M., Samulski, R. J., Zhu, X. D., Hunter, L., Laughlin, C. A., McLaughlin, S., Muzyczka, N., Rocchi, M., & Berns, K. I. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.6.2211 · Cited by 906
Site-specific integration by adeno-associated virus.
Linden, R. M., Ward, P., Giraud, C., Winocour, E., & Berns, K. I. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11288 · Cited by 805
Targeted integration of adeno‐associated virus (AAV) into human chromosome 19.
Samulski, R. J., Zhu, X., Xiao, X., Brook, J. D., Housman, D. E., Epstein, N., & Hunter, L. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04964.x · Cited by 783
Ferrari, F. K., Samulski, T., Shenk, T., & Samulski, R. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.5.3227-3234.1996 · Cited by 761
Use of Adeno-Associated Virus as a General Transduction Vector for Mammalian Cells
Muzyczka, N. (1992) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-75608-5_5 · Cited by 756
Cited by
Sorted by citations
Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics
Kay, M., Glorioso, J., & Naldini, L. (2001) · Nature Medicine · doi:10.1038/83324 · Cited by 1,444
Self-citationAAV vectors: is clinical success on the horizon?
Monahan, P. E., & Samulski, R. J. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301109 · Cited by 291
Adeno-associated virus vectors for gene therapy: more pros than cons?
Monahan, P. E., & Samulski, R. J. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(00)01810-4 · Cited by 226
Viral vectors for gene delivery in tissue engineering☆
Zhang, X., & Godbey, W. T. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.03.006 · Cited by 227
Adeno-associated virus vector integration.
Deyle, D. R., & Russell, D. W. (2009) · PubMed · Cited by 206
Self-citationNakai, H., Storm, T. A., & Kay, M. A. (2000) · Nature Biotechnology · doi:10.1038/75390 · Cited by 176
Self-citationKok, M. R., Yamano, S., Lodde, B. M., Wang, J., Couwenhoven, R. I., Yakar, S., Voutetakis, A., LeRoith, D., Schmidt, M., Afione, S. A., et al. (2003) · Human Gene Therapy · doi:10.1089/104303403322542257 · Cited by 190
Wang, L., Nichols, T. C., Read, M. S., Bellinger, D. A., & Verma, I. M. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0031 · Cited by 176
Nakai, H., Storm, T. A., & Kay, M. A. (2000) · Journal of Virology · doi:10.1128/jvi.74.20.9451-9463.2000 · Cited by 194
Self-citationEfficient Gene Targeting Mediated by Adeno-Associated Virus and DNA Double-Strand Breaks
Porteus, M. H., Cathomen, T., Weitzman, M. D., & Baltimore, D. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.10.3558-3565.2003 · Cited by 159
Warnock, J. N., Daigre, C., & Al‐Rubeai, M. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-095-9_1 · Cited by 154
Adeno‐associated virus gene repair corrects a mouse model of hereditary tyrosinemia in vivo†‡
Paulk, N. K., Wursthorn, K., Wang, Z., Finegold, M. J., Kay, M. A., & Grompe, M. (2010) · Hepatology · doi:10.1002/hep.23481 · Cited by 135
Self-citationMiao, C. H., Nakai, H., Thompson, A. R., Storm, T. A., Chiu, W. S., Snyder, R. O., & Kay, M. A. (2000) · Journal of Virology · doi:10.1128/jvi.74.8.3793-3803.2000 · Cited by 130
Self-citationHuttner, N. A., Girod, A., Perabo, L., Edbauer, D., Kleinschmidt, J. A., Büning, H., & Hallek, M. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302123 · Cited by 124
Recent advances in insulin gene therapy for type 1 diabetes
Yoon, J. W. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02279-7 · Cited by 116
Ponnazhagan, S., Mahendra, G., Curiel, D. T., & Shaw, D. R. (2001) · Journal of Virology · doi:10.1128/jvi.75.19.9493-9501.2001 · Cited by 84
Recombinant Adeno-Associated Virus As Delivery Vector for Gene Therapy—A Review
Yang, L. (2004) · Stem Cells and Development · doi:10.1089/154732804773099335 · Cited by 81
Honaramooz, A., Megee, S. O., Zeng, W., Destrempes, M. M., Overton, S. A., Luo, J., Galantino‐Homer, H. L., Modelski, M. J., Chen, F., Blash, S., et al. (2007) · The FASEB Journal · doi:10.1096/fj.07-8935com · Cited by 83
Knaän‐Shanzer, S., van der Velde, I., Havenga, M. J. E., Lemckert, A. A. C., de Vries, A. A. F., & Valerio, D. (2001) · Human Gene Therapy · doi:10.1089/104303401753204562 · Cited by 70
Zeng, W., Tang, L., Bondareva, A. A., Honaramooz, A., Tanco, V. M., Dores, C. B., Megee, S. O., Modelski, M. J., Rodriguez‐Sosa, J. R., Paczkowski, M., et al. (2012) · Biology of Reproduction · doi:10.1095/biolreprod.112.104422 · Cited by 66
Gene Therapy Using Hematopoietic Stem Cells: Sisyphus Approaches the Crest
Halene, S., & Kohn, D. B. (2000) · Human Gene Therapy · doi:10.1089/10430340050032366 · Cited by 63
Takeda, S., Takahashi, M., Mizukami, H., Kobayashi, E., Takeuchi, K., Hakamata, Y., Kaneko, T., Yamamoto, H., Ito, C., Ozawa, K., et al. (2004) · Nephron Experimental Nephrology · doi:10.1159/000077378 · Cited by 63
Nanomaterials for medical diagnosis and therapy
Kumar, C. S. S. R. (2007) · Cited by 56
Scalable production of adeno‐associated virus type 2 vectors via suspension transfection
Park, J. Y., Lim, B., Lee, K., Kim, Y. K., & Jo, E. (2006) · Biotechnology and Bioengineering · doi:10.1002/bit.20776 · Cited by 55
Yagi, H., Ogura, T., Mizukami, H., Urabe, M., Hamada, H., Yoshikawa, H., Ozawa, K., & Kume, A. (2011) · The Journal of Gene Medicine · doi:10.1002/jgm.1543 · Cited by 50
Adeno-Associated Virus Vectors for Therapeutic Gene Transfer
Stilwell, J. L., & Samulski, R. J. (2003) · BioTechniques · doi:10.2144/03341dd01 · Cited by 52
Kinetics of Recombinant Adeno-Associated Virus-Mediated Gene Transfer
Malik, A. K., Monahan, P. E., Allen, D. L., Chen, B.-G., Samulski, R. J., & Kurachi, K. (2000) · Journal of Virology · doi:10.1128/jvi.74.8.3555-3565.2000 · Cited by 48
Lai, C., Estcourt, M. J., Wikström, M. E., Himbeck, R. P., Barnett, N. L., Brankov, M., Tee, L. B. G., Dunlop, S. A., Degli‐Esposti, M. A., & Rakoczy, E. P. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-3253 · Cited by 46
CRISPR/Cas Applications in Myotonic Dystrophy: Expanding Opportunities
Raaijmakers, R. H. L., Ripken, L., Ausems, C. R. M., & Wansink, D. G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153689 · Cited by 46
Tockary, T. A., Foo, W., Dirisala, A., Chen, Q., Uchida, S., Osawa, S., Mochida, Y., Liu, X., Kinoh, H., Cabral, H., et al. (2019) · ACS Nano · doi:10.1021/acsnano.9b04676 · Cited by 42
Gene therapy: principles and applications to hematopoietic cells
Tendeloo, V. F. V., Broeckhoven, C. V., & Berneman, Z. N. (2001) · Leukemia · doi:10.1038/sj.leu.2402085 · Cited by 37
Adeno-associated virus vectors for gene transfer to the brain
Okada, T., Nomoto, T., Shimazaki, K., Wang, L., Lu, Y., Matsushita, T., Mizukami, H., Urabe, M., Hanazono, Y., Kume, A., et al. (2002) · Methods · doi:10.1016/s1046-2023(02)00228-1 · Cited by 37
Paulk, N. K., Loza, L. I. M., Finegold, M. J., & Grompe, M. (2012) · Human Gene Therapy · doi:10.1089/hum.2012.038 · Cited by 35
Yamano, S., Huang, L.-Y., Ding, C., Chiorini, J. A., Goldsmith, C. M., Wellner, R. B., Golding, B., Kotin, R. M., Scott, D. E., & Baum, B. J. (2002) · Human Gene Therapy · doi:10.1089/10430340252769806 · Cited by 35
Srivastava, A. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.792 · Cited by 35
Hendrie, P. C., Hirata, R. K., & Russell, D. W. (2003) · Journal of Virology · doi:10.1128/jvi.77.24.13136-13145.2003 · Cited by 33
Self-citationAdipose Tissue as a Novel Target for In Vivo Gene Transfer by Adeno-Associated Viral Vectors
Mizukami, H., Mimuro, J., Ogura, T., Okada, T., Urabe, M., Kume, A., Sakata, Y., & Ozawa, K. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.921 · Cited by 31
Han, D., Tian, Y., Zhang, M., Zhou, Z., & Lu, J. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302862 · Cited by 29
Potential for germ line transmission after intramyocardial gene delivery by adeno-associated virus
Pachori, A. S., Melo, L. G., Zhang, L., Loda, M. F., Pratt, R. E., & Dzau, V. J. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.140 · Cited by 30
Gene Transfer into Nonhuman Primate Hematopoietic Stem Cells: Implications for Gene Therapy
Hanazono, Y., Terao, K., & Ozawa, K. (2001) · Stem Cells · doi:10.1634/stemcells.19-1-12 · Cited by 29
Srivastava, A. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10053 · Cited by 28
Weltner, J., Anisimov, A., Alitalo, K. K., Otonkoski, T., & Trokovic, R. (2012) · Journal of Virology · doi:10.1128/jvi.06302-11 · Cited by 27
Drug Therapy for Acute Graft-Versus-Host Disease Prophylaxis
Simpson, D. (2000) · Stem Cells and Development · doi:10.1089/15258160050079425 · Cited by 25
Kogure, K., Urabe, M., Mizukami, H., Kume, A., Sato, Y., Monahan, J., & Ozawa, K. (2001) · International Journal of Hematology · doi:10.1007/bf02994009 · Cited by 24
Primary T Lymphocytes as Targets for Gene Therapy
Hanazono, Y., Brown, K. E., & Dunbar, C. E. (2000) · Stem Cells and Development · doi:10.1089/15258160050196641 · Cited by 24
Hematopoietic Stem Cell Gene Therapy
Emery, D. W., Nishino, T., Murata, K., Fragkos, M., & Stamatoyannopoulos, G. (2002) · International Journal of Hematology · doi:10.1007/bf02982035 · Cited by 23
Okada, T., Mizukami, H., Urabe, M., Nomoto, T., Matsushita, T., Hanazono, Y., Kume, A., Tobita, K., & Ozawa, K. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5730 · Cited by 21
Techniques for the Study of Adult Stem Cells: Be Fruitful and Multiply
Ramos, C. A., Bowman, T. V., Camargo, F. D., & Goodell, M. A. (2003) · BioTechniques · doi:10.2144/03343rv01 · Cited by 20
Yamano, S., Scott, D. E., Huang, L.-Y., Mikolajczyk, M. G., Pillemer, S. R., Chiorini, J. A., Golding, B., & Baum, B. J. (2001) · The Journal of Gene Medicine · doi:10.1002/jgm.213 · Cited by 19
Leray, A., Lalys, P.-A., Varin, J., Bouzelha, M., Bourdon, A., Alvarez-Dorta, D., Pavageau, K., Depienne, S., Marchand, M., Mellet, A., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116148 · Cited by 17
Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.
High, K. A. (2003) · PubMed Central · Cited by 17
Genetically modified dendritic cells – a new, promising cancer treatment strategy?
Wysocki, P. J., Grabarczyk, P., Mackiewicz-Wysocka, M., Kowalczyk, D. W., & Mackiewicz, A. (2002) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2.8.835 · Cited by 17
Vos, J. D., Bagnis, C., Bonnafoux, L., Requirand, G., Jourdan, M., Imbert, M.-C., Jourdan, É., Rossi, J., Mannoni, P., & Klein, B. (2003) · Human Gene Therapy · doi:10.1089/104303403322611746 · Cited by 15
Paz, H., Wong, C., Li, W., Santat, L. A., Wong, K. K., & Chatterjee, S. (2007) · Human Gene Therapy · doi:10.1089/hum.2006.188 · Cited by 15
Hurez, V. J., Hatton, R. D., Oliver, J. R., Matthews, R. J., & Weaver, C. T. (2002) · Immunologic Research · doi:10.1385/ir:26:1-3:131 · Cited by 15
Kim, Y. D., Park, K.-G., Morishita, R., Kaneda, Y., Kim, S.-Y., Song, D.-K., Kim, H., Nam, C., Lee, H. C., Lee, K., et al. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302644 · Cited by 14
AAV induces hepatic necroptosis and carcinoma in diabetic and obese mice dependent on Pebp1 pathway
Cheng, Y., Zhang, Z., Gao, P., Lai, H., Zhong, W., Feng, N., Yang, Y., Yu, H., Zhang, Y., Han, Y., et al. (2023) · EMBO Molecular Medicine · doi:10.15252/emmm.202217230 · Cited by 12
A Promising Genetic Approach to the Treatment of b-Thalassemia
May, C. (2001) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00125-6 · Cited by 12
Godbey, W. T. (2014) · Elsevier eBooks · doi:10.1016/b978-1-907568-28-2.00013-7 · Cited by 10
Adeno-associated virus for cystic fibrosis gene therapy
Martini, S. V., Rocco, P. R. M., & Morales, M. M. (2011) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2011007500123 · Cited by 13
Gene therapy for paediatric leukaemia
Heslop, H. E., Rousseau, R. F., & Bollard, C. M. (2001) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.1.4.663 · Cited by 8
AAV2-mediated follistatin overexpression induces ovine primary myoblasts proliferation
Nazari, M., Salabi, F., Zhang, L., Zhao, F., Wei, C., & Du, L. (2014) · BMC Biotechnology · doi:10.1186/s12896-014-0087-7 · Cited by 6
Gene Delivery to Human and Murine Primitive Hematopoietic Stem and Progenitor Cells by AAV2 Vectors
Srivastava, A. (2004) · Humana Press eBooks · doi:10.1385/1-59259-650-9:245 · Cited by 6
Trahair, T. N., Alexander, I. E., Rowe, P. B., & Smythe, J. A. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-12-2983 · Cited by 6
Microfluidic devices for gene delivery systems
Ahmadi, S., Rabiee, N., Bagherzadeh, M., & Karimi, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818791-3.00010-3 · Cited by 5
Schilder, B. M., Murphy, K. B., Dash, H., Zhang, Y., Gordon-Smith, R., Chapman, J., Otani, M., & Skene, N. (2023) · medRxiv · doi:10.1101/2023.02.13.23285820 · Cited by 5
Bagnis, C. (2014) · Blood Reviews · doi:10.1016/j.blre.2014.10.004 · Cited by 4
Viral Vectors for Gene Therapy
Warnock, J. N., & Al‐Rubeai, M. (2014) · Wiley eBooks · doi:10.1002/9780470054581.eib626.pub2 · Cited by 4
Cord Blood Hematopoietic Cell Transplantation
Broxmeyer, H. E., & Smith, F. O. (2003) · doi:10.1002/9780470987070.ch43 · Cited by 4
Hypocretin/Orexin Replacement Therapy in Hypocretin/Orexin-Deficient Narcolepsy
Fujiki, N., & Nishino, S. (2006) · Contemporary clinical neuroscience · doi:10.1385/1-59259-950-8:367 · Cited by 3
Dong, W.-J., Wu, X., Liu, D., Li, J., Liu, G., Zu, Z.-X., Zhao, N., Hou, Y., & Liang, C. (2002) · Journal of Biomedical Science · doi:10.1007/bf02256072 · Cited by 3
Adipose Tissue as a Novel Target for In Vivo Gene Transfer by Adeno-Associated Viral Vectors
Mizukami, H., Mimuro, J., Ogura, T., Okada, T., Urabe, M., Kume, A., Sakata, Y., & Ozawa, K. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.ft-235 · Cited by 2
GENE THERAPY FOR T-CELL IMMUNODEFICIENCIES
Kohn, D. B., Weinberg, K. I., & Parkman, R. (2000) · Immunology and Allergy Clinics of North America · doi:10.1016/s0889-8561(05)70143-0 · Cited by 2
ADENO-ASSOCIATED VIRUS DISPLAY: IN VITRO EVOLUTION OF AAV RETARGETED VECTORS
Perabò, L. (2003) · Cited by 2
Cardiac Cell and Gene Transfer
Metzger, J. M. (2002) · Humana Press eBooks · doi:10.1385/159259350x · Cited by 2
New innovations for ocular gene therapy
Igarashi, T., Miyake, K., Kobayashi, M., Takahashi, K., Nakamoto, K., Okada, T., & Takahashi, H. (2017) · Nihon Ika Daigaku Igakkai Zasshi · doi:10.1272/manms.13.88 · Cited by 1
Godbey, W. T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817726-6.00012-5 · Cited by 1
Nanotechnologies for Targeted Delivery of Drugs
Brož, P., & Hunziker, P. (2003) · Wiley eBooks · doi:10.1002/9783527610419.ntls0111 · Cited by 1
Methods for Gene Transfer: Genetic Manipulation of Hematopoietic Stem Cells
Moritz, T., & Williams, D. A. (2003) · doi:10.1002/9780470987070.ch10 · Cited by 1
Tipología textual pragmática y didáctica de la traducción en el ámbito biomédico
Serrano, M. B. M. (2011) · Cited by 1
Huttner, N. A. (2003) · doi:10.5282/edoc.1420 · Cited by 1
Theoretical and Technical Considerations for Gene Transfer into Vascularized Cardiac Transplants
Lu, G., & Bishop, D. K. (2003) · Humana Press eBooks · doi:10.1385/1-59259-350-x:135 · Cited by 1
Gene therapy using AAV (adeno-associated virus) vectors
Ozawa, K. (2003) · Uirusu · doi:10.2222/jsv.53.163 · Cited by 1
Genetic Manipulation of Hematopoietic Stem Cells
Adair, J. E., Trobridge, G. D., & Kiem, H. (2015) · doi:10.1002/9781118416426.ch8 · Cited by 1
Srivastava, A. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.ft-81 · Cited by 1
Gene Therapy of Chronic Lymphocytic Leukemia
Castro, J. E., & Kipps, T. J. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-412-2_18 · Cited by 1
Genetic Manipulation of Hematopoietic Stem Cells
Trobridge, G., & Kiem, H. (2009) · doi:10.1002/9781444303537.ch10
Gene Therapy of Haemopoietic Disorders
Rousseau, R. F., & Brenner, M. K. (2005) · doi:10.1002/9780470987056.ch27
Development and Application of Gene Therapy Technologies
Ozawa, K. (2004) · Uirusu · doi:10.2222/jsv.54.49
Site-directed integration using the Cre/lox system in hematopoietic and embryonic stem cells
Faulkes, S. (2009) · cIRcle (University of British Columbia) · doi:10.14288/1.0090532
Current status of gene therapy and prospect of its clinical application.
Ozawa, K. (1999) · Japanese Journal of Clinical Immunology · doi:10.2177/jsci.22.391
Gene Therapy of Pediatric Leukemia
Heslop, H. E. (2000) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)30082-9
Parvovirus Vectors for the Gene Therapy of Cancer
Wong, K. K., & Chatterjee, S. (2002) · Elsevier eBooks · doi:10.1016/b978-012437551-2/50004-5
In vivo Gene electrotransfer: optimisation and mechanisms.
André, F. M. (2006)
Adipose Tissue as a Novel Target for In Vivo Gene Transfer by Adeno-Associated Viral Vectors
Mizukami, H., Mimuro, J., Ogura, T., Okada, T., Urabe, M., Kume, A., Sakata, Y., & Ozawa, K. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.ft-233
GENE THERAPY FOR T-CELL IMMUNODEFICIENCIES
Kohn, D. B., Weinberg, K. I., & Parkman, R. (2000) · Radiologic Clinics of North America · doi:10.1016/s0033-8389(22)00188-9
Biomanufacturing Aspects of Gene Therapy
Warnock, J. N. (2023) · Cell engineering · doi:10.1007/978-3-031-45669-5_14
Ciron, C. (2006) · OpenGrey (Institut de l'Information Scientifique et Technique)
Adeno‐Associated Virus ( AAV )
(2004) · Encyclopedic Dictionary of Genetics, Genomics and Proteomics · doi:10.1002/0471684228.egp00189
Metadata
- Authors
- Russell, D. W., & Kay, M. A.
- Affiliations
- University of Washington (US)
- ORCID
- Kay, Mark A.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1999-08-01
- Volume
- 94
- Issue
- 3
- Pages
- 864-874
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- PMC
- PMC3739711
- OpenAlex
- W1519039806
- Cited by
- 104
- References
- 137
- Citations by year
- 2026: 1 · 2024: 1 · 2023: 3 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 2 · 2016: 1 · 2015: 1 · 2014: 4 · 2012: 4
- FWCI
- 6.18
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01HL053750, HL 53682, HL53750, R01HL053682)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK055759)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Health Sciences › Medicine › Hematology › Hemophilia Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- adeno-associated virus vectors, hematopoietic stem cells, gene therapy, retroviral vectors, factor IX, hemophilia B, erythropoietin, hematocrit, secreted proteins, cytokines, coagulation factors
- MeSH terms
- Dependovirus, Animals, Genetic Vectors, Hematologic Diseases, Humans, Genetic Therapy, Gene Transfer Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review